Advertisement
Paucity of models hinders development of treatments for this lethal disease
Research to investigate non-invasive method aims to identify patients at risk for osteoarthritis
APOL1 gene variants are associated with increased risk
A possible association between ACE2 and TMPRSS2 polymorphisms and COVID-19 susceptibility
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
New research elucidates key role of WISP1 protein
$2 million will enable preclinical dose and efficacy testing of “compound 3”
Largest-to-date evaluation of germline mutations in this population demonstrates the value of genetics evaluation and genetic testing
Bruce Trapp, PhD, reflects on decades of basic and translational research
$2M NIH grant will help see if dual-action agent lengthens treatment window
Meet the Director of Cleveland Clinic’s new Center for Immunotherapy and Precision Immuno-Oncology
Advertisement
Advertisement